{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:49:01Z","timestamp":1789044541212,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,28]]},"DOI":"10.7759\/cureus.28513","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T01:31:45Z","timestamp":1661736705000},"source":"Crossref","is-referenced-by-count":8,"title":["The Ophthalmic Side Effects of Topiramate: A Review"],"prefix":"10.7759","author":[{"given":"Monia","family":"Mechrgui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suleman","family":"Kanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-017-0740-y","article-title":"Bilateral acute angle closure glaucoma and myopic shift by topiramate-induced ciliochoroidal effusion: case report and literature review","volume":"38","author":"Lan YW","year":"2018","unstructured":"Lan YW, Hsieh JW. Bilateral acute angle closure glaucoma and myopic shift by topiramate-induced ciliochoroidal effusion: case report and literature review. Int Ophthalmol. 2018, 38:2639-2648. 10.1007\/s10792-017-0740-y","journal-title":"Int Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1997.0124","article-title":"A pharmacological and clinical review on topiramate, a new antiepileptic drug","volume":"35","author":"Perucca E","year":"1997","unstructured":"Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacol Res. 1997, 35:241-256. 10.1006\/phrs.1997.0124","journal-title":"Pharmacol Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.6b00176","article-title":"Phenotypic assessment and the discovery of topiramate","volume":"7","author":"Maryanoff BE","year":"2016","unstructured":"Maryanoff BE. Phenotypic assessment and the discovery of topiramate. ACS Med Chem Lett. 2016, 7:662-665. 10.1021\/acsmedchemlett.6b00176","journal-title":"ACS Med Chem Lett"},{"key":"ref4","unstructured":"Topiramate. Uses, Interactions, Mechanism of Action. (2022). Accessed: July 27, 2022: https:\/\/go.drugbank.com\/drugs\/DB00273."},{"key":"ref5","unstructured":"Topamax (topiramate). Full Prescribing Information. (2012). https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2012\/020844s041lbl.pdf."},{"key":"ref6","unstructured":"Topiramate. (2022). Accessed. July 27, 2022: https:\/\/en.wikipedia.org\/wiki\/Topiramate."},{"key":"ref7","unstructured":"Topamax oral. Uses, Side Effects, Interactions, Pictures, Warnings & Dosing. (2022). Accessed: July 27, 2022: https:\/\/www.webmd.com\/drugs\/2\/drug-14494-6019\/topamax-oral\/topiramate-oral\/details."},{"key":"ref8","article-title":"Review of sulfonamide-induced acute myopia and acute bilateral angle-closure glaucoma","volume":"8","author":"Panday VA","year":"2007","unstructured":"Panday VA, Rhee DJ. Review of sulfonamide-induced acute myopia and acute bilateral angle-closure glaucoma. Compr Ophthalmol Update. 2007, 8:271-276.","journal-title":"Compr Ophthalmol Update"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S27695","article-title":"Topiramate and the vision: a systematic review","volume":"6","author":"Abtahi MA","year":"2012","unstructured":"Abtahi MA, Abtahi SH, Fazel F, Roomizadeh P, Etemadifar M, Jenab K, Akbari M. Topiramate and the vision: a systematic review. Clin Ophthalmol. 2012, 6:117-131. 10.2147\/OPTH.S27695","journal-title":"Clin Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2016.05.003","article-title":"Acetazolamide-induced bilateral ciliochoroidal effusion syndrome in plateau iris configuration","volume":"3","author":"Man X","year":"2016","unstructured":"Man X, Costa R, Ayres BM, Moroi SE. Acetazolamide-induced bilateral ciliochoroidal effusion syndrome in plateau iris configuration. Am J Ophthalmol Case Rep. 2016, 3:14-17. 10.1016\/j.ajoc.2016.05.003","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5301\/EJO.2010.5979","article-title":"Topiramate-induced acute bilateral angle closure and myopia: pathophysiology and treatment controversies","volume":"21","author":"van Issum C","year":"2011","unstructured":"van Issum C, Mavrakanas N, Schutz JS, Shaarawy T. Topiramate-induced acute bilateral angle closure and myopia: pathophysiology and treatment controversies. Eur J Ophthalmol. 2011, 21:404-409. 10.5301\/EJO.2010.5979","journal-title":"Eur J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2009.09.020","article-title":"Bilateral acute angle-closure glaucoma in a migraine patient receiving topiramate: a case report","volume":"43","author":"Cole KL","year":"2012","unstructured":"Cole KL, Wang EE, Aronwald RM. Bilateral acute angle-closure glaucoma in a migraine patient receiving topiramate: a case report. J Emerg Med. 2012, 43:e89-e91. 10.1016\/j.jemermed.2009.09.020","journal-title":"J Emerg Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(01)01013-3","article-title":"Presumed topiramate-induced bilateral acute angle-closure glaucoma","volume":"132","author":"Banta JT","year":"2001","unstructured":"Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol. 2001, 132:112-114. 10.1016\/s0002-9394(01)01013-3","journal-title":"Am J Ophthalmol"},{"key":"ref14","article-title":"Bilateral angle-closure glaucoma and ciliary body swelling from topiramate","volume":"119","author":"Rhee DJ","year":"2001","unstructured":"Rhee DJ, Goldberg MJ, Parrish RK. Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol. 2001, 119:1721-1723.","journal-title":"Arch Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9394(03)00774-8","article-title":"Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma","volume":"137","author":"Craig JE","year":"2004","unstructured":"Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol. 2004, 137:193-195. 10.1016\/s0002-9394(03)00774-8","journal-title":"Am J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00061198-200304000-00013","article-title":"Possible mechanisms of primary angle-closure and malignant glaucoma","volume":"12","author":"Quigley HA","year":"2003","unstructured":"Quigley HA, Friedman DS, Congdon NG. Possible mechanisms of primary angle-closure and malignant glaucoma. J Glaucoma. 2003, 12:167-180. 10.1097\/00061198-200304000-00013","journal-title":"J Glaucoma"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.01.021","article-title":"Rapid resolution of topiramate-induced angle-closure glaucoma with methylprednisolone and mannitol","volume":"141","author":"Rhee DJ","year":"2006","unstructured":"Rhee DJ, Ramos-Esteban JC, Nipper KS. Rapid resolution of topiramate-induced angle-closure glaucoma with methylprednisolone and mannitol. Am J Ophthalmol. 2006, 141:1133-1134. 10.1016\/j.ajo.2006.01.021","journal-title":"Am J Ophthalmol"},{"key":"ref18","unstructured":"Topiramate-induced angle closure. (2019). Accessed. July 27, 2022: https:\/\/webeye.ophth.uiowa.edu\/eyeforum\/cases\/283-topiramate-induced-angle-closure.htm."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.04.004","article-title":"Topiramate-associated acute, bilateral, secondary angle-closure glaucoma","volume":"111","author":"Fraunfelder FW","year":"2004","unstructured":"Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology. 2004, 111:109-111. 10.1016\/j.ophtha.2003.04.004","journal-title":"Ophthalmology"},{"key":"ref20","article-title":"A novel presentation and therapy for topiramate induced myopic shift","volume":"48","author":"Edell E","year":"2007","unstructured":"Edell E, Nissman SA, Schwartz A. A novel presentation and therapy for topiramate induced myopic shift. Invest Ophthalmol Vis Sci. 2007, 48:1027.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/0974-620X.60018","article-title":"Topiramate-induced angle closure with acute myopia, macular striae","volume":"3","author":"Natesh S","year":"2010","unstructured":"Natesh S, Rajashekhara SK, Rao AS, Shetty B. Topiramate-induced angle closure with acute myopia, macular striae. Oman J Ophthalmol. 2010, 3:26-28. 10.4103\/0974-620X.60018","journal-title":"Oman J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2015.02.008","article-title":"Topiramate-induced myopic shift with associated retinal striae","volume":"50","author":"Sears N","year":"2015","unstructured":"Sears N, Modi YS, Engel R, Singh RP. Topiramate-induced myopic shift with associated retinal striae. Can J Ophthalmol. 2015, 50:e46-e50. 10.1016\/j.jcjo.2015.02.008","journal-title":"Can J Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.oftal.2019.07.014","article-title":"Macular neurosensory retinal detachment associated with topiramate use","volume":"94","author":"Mu\u00f1oz Morales A","year":"2019","unstructured":"Mu\u00f1oz Morales A, S\u00e1nchez-Vicente JL, Franco Ruedas C, de Las Morenas Iglesias J, Espi\u00f1eira Peri\u00f1\u00e1n M\u00c1, L\u00f3pez-Herrero F. Macular neurosensory retinal detachment associated with topiramate use. Arch Soc Esp Oftalmol (Engl Ed). 2019, 94:614-618. 10.1016\/j.oftal.2019.07.014","journal-title":"Arch Soc Esp Oftalmol (Engl Ed)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2147\/DHPS.S105962","article-title":"Topiramate-induced maculopathy in IgG4-related disease","volume":"8","author":"DaCosta J","year":"2016","unstructured":"DaCosta J, Younis S. Topiramate-induced maculopathy in IgG4-related disease. Drug Healthc Patient Saf. 2016, 8:59-63. 10.2147\/DHPS.S105962","journal-title":"Drug Healthc Patient Saf"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-012-9640-3","article-title":"Topiramate maculopathy","volume":"33","author":"Gualtieri W","year":"2013","unstructured":"Gualtieri W, Janula J. Topiramate maculopathy. Int Ophthalmol. 2013, 33:103-106. 10.1007\/s10792-012-9640-3","journal-title":"Int Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2017.05.005","article-title":"Topiramate-induced macular neurosensory retinal detachment","volume":"7","author":"Rosenberg K","year":"2017","unstructured":"Rosenberg K, Maguire J, Benevento J. Topiramate-induced macular neurosensory retinal detachment. Am J Ophthalmol Case Rep. 2017, 7:31-37. 10.1016\/j.ajoc.2017.05.005","journal-title":"Am J Ophthalmol Case Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2010.523805","article-title":"Topiramate-induced bilateral anterior uveitis associated with hypopyon formation","volume":"19","author":"Jabbarpoor Bonyadi MH","year":"2011","unstructured":"Jabbarpoor Bonyadi MH, Soheilian R, Soheilian M. Topiramate-induced bilateral anterior uveitis associated with hypopyon formation. Ocul Immunol Inflamm. 2011, 19:86-88. 10.3109\/09273948.2010.523805","journal-title":"Ocul Immunol Inflamm"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S104847","article-title":"Is uveitis associated with topiramate use? A cumulative review","volume":"10","author":"Goldberg JL","year":"2016","unstructured":"Goldberg JL, Lau AG, Fan B, Ford L, Greenberg HE. Is uveitis associated with topiramate use? A cumulative review. Clin Ophthalmol. 2016, 10:1467-1470. 10.2147\/OPTH.S104847","journal-title":"Clin Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1192_17","article-title":"Topiramate-induced acute angle closure with severe panuveitis: a challenging case report","volume":"66","author":"Mahendradas P","year":"2018","unstructured":"Mahendradas P, Parab S, Sasikumar R, Kawali A, Shetty BK. Topiramate-induced acute angle closure with severe panuveitis: a challenging case report. Indian J Ophthalmol. 2018, 66:1342-1344. 10.4103\/ijo.IJO_1192_17","journal-title":"Indian J Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2014-203787","article-title":"Acute bilateral glaucoma and panuveitis as a side effect of topiramate for weight loss treatment","volume":"2014","author":"Pikkel YY","year":"2014","unstructured":"Pikkel YY. Acute bilateral glaucoma and panuveitis as a side effect of topiramate for weight loss treatment. BMJ Case Rep. 2014, 2014:10.1136\/bcr-2014-203787","journal-title":"BMJ Case Rep"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2016.03.002","article-title":"Topiramate associated non-glaucomatous visual field defects","volume":"31","author":"Haque S","year":"2016","unstructured":"Haque S, Shaffi M, Tang KC. Topiramate associated non-glaucomatous visual field defects. J Clin Neurosci. 2016, 31:210-213. 10.1016\/j.jocn.2016.03.002","journal-title":"J Clin Neurosci"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(03)00051-1","article-title":"Foggy visual field defect","volume":"48","author":"Foroozan R","year":"2003","unstructured":"Foroozan R, Buono LM. Foggy visual field defect. Surv Ophthalmol. 2003, 48:447-451. 10.1016\/s0039-6257(03)00051-1","journal-title":"Surv Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.4321\/s0365-66912006000600010","article-title":"[Severe ocular side effects with Topamax]","volume":"81","author":"Asensio-S\u00e1nchez VM","year":"2006","unstructured":"Asensio-S\u00e1nchez VM, Torreblanca-Ag\u00fcera B, Mart\u00ednez-Calvo S, Calvo MJ, Rodr\u00edguez R. [Severe ocular side effects with Topamax]. Arch Soc Esp Oftalmol. 2006, 81:345-348. 10.4321\/s0365-66912006000600010","journal-title":"Arch Soc Esp Oftalmol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-1069-1","article-title":"Visual field defects--essentials for neurologists","volume":"250","author":"Schiefer U","year":"2003","unstructured":"Schiefer U. Visual field defects--essentials for neurologists. J Neurol. 2003, 250:407-411. 10.1007\/s00415-003-1069-1","journal-title":"J Neurol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-006-9027-8","article-title":"Retinal function and histopathology in rabbits treated with Topiramate","volume":"113","author":"Kjellstr\u00f6m S","year":"2006","unstructured":"Kjellstr\u00f6m S, Bruun A, Isaksson B, Eriksson T, Andr\u00e9asson S, Ponjavic V. Retinal function and histopathology in rabbits treated with Topiramate. Doc Ophthalmol. 2006, 113:179-186. 10.1007\/s10633-006-9027-8","journal-title":"Doc Ophthalmol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.45156","article-title":"Ocular adverse effects of topiramate: two case reports","volume":"40","author":"Mandal A","year":"2008","unstructured":"Mandal A, Chatterjee S, Bose S, Ganguly G. Ocular adverse effects of topiramate: two case reports. Indian J Pharmacol. 2008, 40:278-280. 10.4103\/0253-7613.45156","journal-title":"Indian J Pharmacol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10369","article-title":"Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies","volume":"27","author":"Oh SJ","year":"2003","unstructured":"Oh SJ, Alapati A, Claussen GC, Vernino S. Myokymia, neuromyotonia, dermatomyositis, and voltage-gated K+ channel antibodies. Muscle Nerve. 2003, 27:757-760. 10.1002\/mus.10369","journal-title":"Muscle Nerve"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7901085","article-title":"Topiramate-induced persistent eyelid myokymia","volume":"2016","author":"Khalkhali M","year":"2016","unstructured":"Khalkhali M. Topiramate-induced persistent eyelid myokymia. Case Rep Psychiatry. 2016, 2016:7901085. 10.1155\/2016\/7901085","journal-title":"Case Rep Psychiatry"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12395","article-title":"Eyelid myokymia in patients with migraine taking topiramate","volume":"132","author":"Medrano-Mart\u00ednez V","year":"2015","unstructured":"Medrano-Mart\u00ednez V, P\u00e9rez-Sempere A, Molt\u00f3-Jord\u00e1 JM, Fern\u00e1ndez-Izquierdo S, Franc\u00e9s-Pont I, Mallada-Frechin J, Piqueras-Rodr\u00edguez L. Eyelid myokymia in patients with migraine taking topiramate. Acta Neurol Scand. 2015, 132:143-146. 10.1111\/ane.12395","journal-title":"Acta Neurol Scand"},{"key":"ref40","unstructured":"Oculogyric crisis. (2022). Accessed. July 27, 2022: https:\/\/en.wikipedia.org\/wiki\/Oculogyric_crisis."},{"key":"ref41","unstructured":"Topiramate and Oculogyric crisis - a phase IV clinical study of FDA data. (2022). Accessed. July 27, 2022: https:\/\/www.ehealthme.com\/ds\/topiramate\/oculogyric-crisis\/."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.4103\/1817-1745.147612","article-title":"Alice in Wonderland syndrome: a rare neurological manifestation with microscopy in a 6-year-old child","volume":"9","author":"Weissenstein A","year":"2014","unstructured":"Weissenstein A, Luchter E, Bittmann MA. Alice in Wonderland syndrome: a rare neurological manifestation with microscopy in a 6-year-old child. J Pediatr Neurosci. 2014, 9:303-304. 10.4103\/1817-1745.147612","journal-title":"J Pediatr Neurosci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.2006.00458_1.x","article-title":"Reversible palinopsia and the Alice in Wonderland syndrome associated with topiramate use in migraineurs","volume":"46","author":"Evans RW","year":"2006","unstructured":"Evans RW. Reversible palinopsia and the Alice in Wonderland syndrome associated with topiramate use in migraineurs. Headache. 2006, 46:815-818. 10.1111\/j.1526-4610.2006.00458_1.x","journal-title":"Headache"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2009.187245","article-title":"\"Alice in Wonderland syndrome\" associated with topiramate for migraine prevention","volume":"82","author":"J\u00fcrgens TP","year":"2011","unstructured":"J\u00fcrgens TP, Ihle K, Stork JH, May A. \"Alice in Wonderland syndrome\" associated with topiramate for migraine prevention. J Neurol Neurosurg Psychiatry. 2011, 82:228-229. 10.1136\/jnnp.2009.187245","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref45","unstructured":"Palinopsia. (2022). Accessed. July 27, 2022: https:\/\/eyewiki.aao.org\/Palinopsia#:%7E:text=Images%20from%20palinopsia%20are%20positive,hallucinatory%20palinopsia%2...."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/WNO.0000000000000216","article-title":"Topiramate-induced palinopsia: a case series and review of the literature","volume":"35","author":"Yun SH","year":"2015","unstructured":"Yun SH, Lavin PJ, Schatz MP, Lesser RL. Topiramate-induced palinopsia: a case series and review of the literature. J Neuroophthalmol. 2015, 35:148-151. 10.1097\/WNO.0000000000000216","journal-title":"J Neuroophthalmol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.14744\/bej.2019.07379","article-title":"Topiramate-induced acute myopia, diplopia, and photosensitivity: a case report","volume":"4","author":"Kocamaz M","year":"2019","unstructured":"Kocamaz M, Karadag O. Topiramate-induced acute myopia, diplopia, and photosensitivity: a case report. Beyoglu Eye J. 2019, 4:42-45. 10.14744\/bej.2019.07379","journal-title":"Beyoglu Eye J"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3129\/i09-017","article-title":"Topiramate-induced acute-onset myopia and central corneal thickening: Pentacam Scheimpflug imaging findings","volume":"44","author":"Kerimoglu H","year":"2009","unstructured":"Kerimoglu H, Tokgoz M, Ozturk B, Gonul S, Pekel H. Topiramate-induced acute-onset myopia and central corneal thickening: Pentacam Scheimpflug imaging findings. Can J Ophthalmol. 2009, 44:222-223. 10.3129\/i09-017","journal-title":"Can J Ophthalmol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.01.121","article-title":"Acquired trichomegaly with topiramate","volume":"53","author":"Santmyire-Rosenberger BR","year":"2005","unstructured":"Santmyire-Rosenberger BR, Albert M. Acquired trichomegaly with topiramate. J Am Acad Dermatol. 2005, 53:362-363. 10.1016\/j.jaad.2005.01.121","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/108227-the-ophthalmic-side-effects-of-topiramate-a-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:53Z","timestamp":1707508193000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/108227-the-ophthalmic-side-effects-of-topiramate-a-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,28]]},"references-count":49,"URL":"https:\/\/doi.org\/10.7759\/cureus.28513","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,28]]}}}